ArticleStroke (Hoboken, N.J.)2025
Redefining Ischemic Core, Penumbra, and Target Mismatch on Perfusion Imaging in Acute Anterior Distal Medium Vessel Occlusion.
Article in Stroke (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative validation of automated perfusion analysis software for ischemic penumbra estimation and EVT decision-making.Frontiers in neuroscience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecent trials of endovascular thrombectomy (EVT) for acute distal medium vessel occlusions (DMVOs) were negative but also used inconsistent imaging-based inclusion criteria, whereas many successful large vessel occlusion (LVO) EVT trials used empirically validated perfusion imaging-based target mismatch (TMM) criteria: an ischemic penumbra (time-to-maximum [Tmax] >6 s) to core (relative cerebral blood flow [rCBF] <30%) mismatch ratio ≥1.8 and mismatch volume ≥15 mL. We aimed to determine optimal corresponding definitions in DMVOs to improve patient selection for EVT.
methodsWe retrospectively analyzed patients with acute anterior DMVOs from prospectively collected databases at 4 comprehensive stroke centers. To assess core, we evaluated how well pretreatment rCBF <20%, <30%, <34%, and <38% volumes correlated with magnetic resonance imaging-based posttreatment follow-up infarct volumes in successfully recanalized patients. To evaluate penumbra, we assessed how well pretreatment Tmax >4 s, >6 s, >8 s, and >10 s volumes correlated with follow-up infarct volumes in unrecanalized patients. Then, we evaluated whether these improved parameters for core and penumbra better quantified LVO TMM and identified an optimal DMVO TMM definition.
resultsIn 122 core (recanalized) patients, rCBF <38% most strongly correlated with follow-up infarct volumes (concordance correlation coefficient 0.30 [95% CI, 0.15-0.48]), outperforming rCBF <30% (concordance correlation coefficient 0.21 [0.10-0.35]) (
conclusionIn acute anterior DMVOs, rCBF <38% and Tmax >8 s best correspond to ischemic core and penumbra, respectively; more favorably quantify LVO TMM; and reveal optimal TMM criteria. These results should be prospectively investigated as inclusion criteria for EVT in this population and suggest recent negative DMVO EVT trials may have been confounded by suboptimal patient selection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.